Edison vs. Tesla: The tale of 2 prolific innovators and the different routes they took to commercialization
1400 Washington Ave
Albany, NY 12222
Are you considering how to translate your research and inventions into products and services? Interested in bringing your product to market without actually running a business? Have an interesting idea and don’t know how to proceed? Join the Biomedical Acceleration and Commercialization Center (BACC) and the UAlbany Innovation Center for a two-part series focused on the technology licensing process led by Dan Potvin, licensing professional at GE.
Friday, June 21, 2019 – The first seminar in this series will look at the two paths inventors take for commercializing an invention: starting a new venture or licensing to existing companies. This seminar will compare both paths to highlight their advantages and drawbacks. A prime example of these two different strategies is how Edison and Tesla, both prolific inventors of foundational electrical technologies including electric lighting, AC motors, and electric power generation and transmission, each pursued a different path to widespread adoption of their inventions.
Date TBD – The second seminar in this series will investigate more deeply the technology licensing process by working with case studies. As a participant, you will have a chance to look at examples where licensing has worked well and contrast those with situations where it has not, thus gaining a stronger understanding of the best uses of the technology licensing process and how it might work for you.
Dan Potvin is a VP of Licensing at GE in Niskayuna, NY. He leads the development and negotiation of IP licensing programs across a variety of fields including electric vehicles and charging, wireless power transfer, and industrial and electrical systems. Dan has negotiated more than 40 complex licensing transactions and partnerships, and he has enabled the formation of 8 new ventures through IP licensing. Dan’s specialties include patent licensing, technology transfer, commercialization of advanced technology, patent pools, and business development.
Prior to his current role, Dan spent 6 years at the Johns Hopkins University where he managed and licensed a portfolio of life science inventions and participated in the creation of new ventures. Dan started his career as a viral immunologist and developed a deep and sustained interest in intellectual property licensing. He holds a PhD in biomedical sciences from the State University of New York at Albany and a BS in biochemistry/biophysics from Rensselaer Polytechnic Institute.